KIF20A promotes the progression of castration-resistant prostate cancer by activating androgen receptor signaling (Copello and Burnstein, 2022) and promotes the progression of fibrosarcoma via the PI3K-Akt signaling pathway (Jin et al., 2022). Here, KIF20A is linked to fibrosarcoma.